NCT02522728

Brief Summary

The objective is to investigate the Clinical, Radiographic, Roentgen Stereophotogrammetric behaviour and patient outcome when using the Triathlon total knee prosthesis in a prospective randomized clinical trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 23, 2007

Completed
8.4 years until next milestone

First Submitted

Initial submission to the registry

June 11, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 13, 2015

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2017

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

August 2, 2019

Completed
Last Updated

February 22, 2024

Status Verified

February 1, 2024

Enrollment Period

10.6 years

First QC Date

June 11, 2015

Results QC Date

August 22, 2018

Last Update Submit

February 20, 2024

Conditions

Keywords

KneeArthroplastyImplant

Outcome Measures

Primary Outcomes (1)

  • Assessment of Fixation and Stability of the Triathlon Total Knee Prosthesis by Roentgen Stereophotogrammetric Analysis (RSA)

    Roentgen Stereophotogrammetric Analysis (RSA) is a technique to measure migration of prosthesis components relative to the bone which allows conclusions regarding the fixation of an implant. This study assesses the fixation and stability of the Triathlon total knee prosthesis at 2 years by RSA as a predictor of late mechanical loosening.

    2 years follow-up

Secondary Outcomes (4)

  • Investigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS)

    pre-operative, 3 months, 1, 2, 5, 7 and 10 years

  • Investigation of Clinical Performance and Patient Outcome With the Knee Injury and Osteoarthritis Outcome Score (KOOS) Patient Questionnaire

    pre-operative, 3 months, 1, 2, 5, 7 and 10 years

  • Investigation of Clinical Performance and Patient Outcome With EuroQuol-5 Dimension (EQ-5D) Patient Questionnaire

    1, 2, 5, 7 and 10 years

  • Investigation of Patient Outcome With Radiographic Analysis

    3 months, 1, 2, 5, 7 and 10 years

Study Arms (2)

Triathlon CR

ACTIVE COMPARATOR

Triathlon Cruciate Retaining (CR) versus Triathlon Posterior Stabilized (PS): During knee prosthesis surgery the surgeon many times need to make a judgement on if to keep a defect anatomical structure or if to replace it with knee prosthesis with a design that allows for adjustment of this defect. This study is aimed to evaluate which prosthetic choice to be made in respect of stability, long-term results and patient outcome.

Device: Triathlon CR

Triathlon PS

ACTIVE COMPARATOR

Triathlon Cruciate Retaining (CR) versus Triathlon Posterior Stabilized (PS): During knee prosthesis surgery the surgeon many times need to make a judgement on if to keep a defect anatomical structure or if to replace it with knee prosthesis with a design that allows for adjustment of this defect. This study is aimed to evaluate which prosthetic choice to be made in respect of stability, long-term results and patient outcome.

Device: Triathlon PS

Interventions

Implantation of Knee Prosthesis

Triathlon CR

Implantation of Knee Prosthesis

Triathlon PS

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients suffering exclusively from osteo arthritis, Stage II-V \[Ahlbäck, 1968 391\] will be operated.
  • Patients requiring knee prosthesis, suitable for the use of Duracon and Triathlon knee system
  • Patients who understand the conditions of the study and are willing and able to comply with the post-operative scheduled clinical and radiographical evaluations and the prescribed rehabilitation.
  • Patients who signed the Ethics Committee approved Informed Consent Form prior to surgery.

You may not qualify if:

  • Previous major knee surgery
  • Other significant disabling problems from the muscular-skeletal system than in the knees
  • Obese patients where obesity is severe enough to affect subject's ability to perform activities of daily living (body mass index, kg/m2: BMI above 35).
  • Patients with active or suspected infection.
  • Patients with malignancy - active malignancy.
  • Patients with severe osteoporosis, Paget's disease, renal osteodystrophy.
  • Patients immunologically suppressed, or receiving steroids in excess of physiologic dose requirements.
  • The patient has a neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device or the patient has a neurological deficit which interferes with the patient's ability to limit weight bearing or places an extreme load on the implant during the healing period.
  • Female patients planning a pregnancy during the course of the study.
  • Patients with systemic or metabolic disorders leading to progressive bone deterioration.
  • Patients, who as judged by the surgeon, are mentally incompetent or are unlikely to be compliant with the prescribed post-operative routine and follow-up evaluation schedule.
  • Patients with other severe concurrent joint involvements, which can affect their outcome.
  • Patients with other concurrent illnesses, which are likely to affect their outcome such as sickle cell anaemia, systemic lupus erythematosus or renal disease requiring dialysis.
  • Patients under the protection of law (e.g. guardianship).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Skånevård Kryh Division Kirurgi och Ortopedkliniken Hässleholm

Hässleholm, Skåne County, 281 38, Sweden

Location

Results Point of Contact

Title
Eric Garling, PhD Snr. Director Medical & Scientific Affairs Europe
Organization
Stryker Orthopaedics

Study Officials

  • Sören Toksvig-Larsen, MD

    Skånevård Kryh Division Kirurgi och Ortopedkliniken Hässleholm

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2015

First Posted

August 13, 2015

Study Start

January 23, 2007

Primary Completion

September 14, 2017

Study Completion

September 14, 2017

Last Updated

February 22, 2024

Results First Posted

August 2, 2019

Record last verified: 2024-02

Locations